| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 01/26/2005 | EP1120409B1 2,3-disubstituted pyridine derivatives, process for the preparation thereof, drug compositions containing the same and intermediates for the preparation |
| 01/26/2005 | EP1084109B1 2-aminopyridines containing fused ring substituents as nitric oxide synthase inhibitors |
| 01/26/2005 | EP1082303B1 Heterocyclic derivatives which inhibit factor xa |
| 01/26/2005 | EP0983267B1 Amidoaromatic ring sulfonamide hydroxamic acid compounds |
| 01/26/2005 | EP0844877B1 Use of oxido-squalene cyclase inhibitors to lower blood cholesterol |
| 01/26/2005 | CN1571785A Synthesis of 4-[(z)-4-bromophenyl)(ethoxyimino) methyl]-1'-[(2, 4-dimethyl-1-oxido-3-pyridinyl)carbonyl]-4'-methyl-1, 4-'bipiperidine |
| 01/26/2005 | CN1571771A Process for preparing beta-ketoester compound |
| 01/26/2005 | CN1571667A Inhibitors of dipeptidyl peptidase ó¶ |
| 01/26/2005 | CN1186344C Amino acid compounds and use thereof as NEP, ACE and ECE inhibitors |
| 01/26/2005 | CN1186340C C10 carbonate substituted taxanes as antitumor agents |
| 01/26/2005 | CN1186332C New thryoid receptor ligands and process II |
| 01/26/2005 | CN1186323C Process for preparing gamma-(p-formolstyryl) pyridine |
| 01/25/2005 | US6846958 Synthesis of benzimidate from benzoic acid |
| 01/25/2005 | US6846954 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 01/25/2005 | US6846833 Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same |
| 01/25/2005 | US6846830 Naphtalene derivatives and their pharmaceutical use |
| 01/25/2005 | US6846829 N-heterocyclic derivatives as NOS inhibitors |
| 01/25/2005 | US6846826 To maintain hypotension |
| 01/25/2005 | US6846825 Antibacterial agents |
| 01/25/2005 | US6846819 Bactericides compound containing acrylamide group |
| 01/25/2005 | CA2231201C Toilet bowl cleaning tablet |
| 01/25/2005 | CA2159480C (s)-alpha-phenyl-2-pyridineethanamine benzoate and its use as a medicament |
| 01/25/2005 | CA2159478C (s)-alpha-phenyl-2-pyridineethanamine (s)-malate and its use as a medicament |
| 01/20/2005 | WO2005005391A1 In-situ treatment of pyridine-2,3-dicarboxylic acid esters with an oxidizing agent |
| 01/20/2005 | WO2005005389A2 Malonamide derivatives |
| 01/20/2005 | WO2005005376A2 Fungicidal phenoxyphenylhydrazine derivatives |
| 01/20/2005 | WO2005005374A1 Aspartyl protease inhibitors |
| 01/20/2005 | WO2005004866A1 Therapeutic agents useful for treating pain |
| 01/20/2005 | WO2005004810A2 Arylsulfonamide derivatives |
| 01/20/2005 | WO2005004606A2 Pyridinylanilides |
| 01/20/2005 | WO2004099124A3 Novel bioisosteres of actinonin |
| 01/20/2005 | WO2003076443A9 Spiro compounds with npy antagonistic activity |
| 01/20/2005 | US20050014950 Process for the preparation of alpha hydroxycarboxylic acid amides |
| 01/20/2005 | US20050014941 Cyanoalkylamino derivatives as protease inhibitors |
| 01/20/2005 | US20050014840 Thiol sulfonamide metalloprotease inhibitors |
| 01/20/2005 | US20050014833 Cyclic compound and ppar agonist |
| 01/20/2005 | US20050014822 Carbonylamino-substituted acyl phenyl urea derivatives, process for their preparation and their use |
| 01/20/2005 | US20050014800 Vision defects; anticancer agents; antitumor agents |
| 01/20/2005 | US20050014792 Process for preparation of pyridine derivatives |
| 01/20/2005 | US20050014787 5-amidino-2-hydroxybenzenesulfonamide derivatives medicinal compoistions containing the same medicinal use thereof and intermediates in the production thereof |
| 01/20/2005 | US20050014753 Antitumor agents |
| 01/20/2005 | US20050014746 compounds which bind to the interaction-domain (I-domain) of LFA-1, thus interrupting endothelial cell-leukocyte adhesion by blocking the interaction of LFA-1 with ICAM-1, ICAM-3, and other adhesion molecules |
| 01/20/2005 | US20050014741 2-oxo-benzimidazolyl substituted ethanolamine derivatives and their use as beta3 agonists |
| 01/20/2005 | US20050014702 Inhibition of pdf enzyme as bactericidal agents for veterinary medicines |
| 01/20/2005 | US20050014651 Abscisic acid biosynthesis inhibitor |
| 01/20/2005 | US20050014025 Luminescence device, display apparatus and metal coordination compound |
| 01/20/2005 | US20050013862 Functional powders for oral delivery |
| 01/20/2005 | DE10327719A1 VEGFR-2 und VEGFR-3 Inhibitorische Anthranylamidpyridone VEGFR-2 and VEGFR-3 inhibitory Anthranylamidpyridone |
| 01/20/2005 | CA2535986A1 Fungicidal phenoxyphenylhydrazine derivatives |
| 01/20/2005 | CA2531485A1 Malonamide derivatives |
| 01/20/2005 | CA2529739A1 Aspartyl protease inhibitors |
| 01/19/2005 | EP1498413A1 4-Aminopicolinates and their use as herbicides |
| 01/19/2005 | EP1498411A1 Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient |
| 01/19/2005 | EP1497270A1 Amide compounds and methods of using the same |
| 01/19/2005 | EP1497268A2 Nitric oxide donors, compositions and methods of use |
| 01/19/2005 | EP1497261A1 Phenethanolamine derivatives |
| 01/19/2005 | EP1497260A1 Novel methoxybenzamide compounds for use in mch receptor related disorders |
| 01/19/2005 | EP1497247A2 Mimics of acyl coenzyme-a, compositions thereof, and methods of cholesterol management and related uses |
| 01/19/2005 | EP1496900A2 New pharmaceutical compositions based on anticholinergics and p38 kinase inhibitors |
| 01/19/2005 | EP1496838A2 Substituted amides |
| 01/19/2005 | EP1181271B1 Naphthalene ureas as glucose uptake enhancers |
| 01/19/2005 | EP1009729B1 Halogenated acrylates and polymers derived therefrom |
| 01/19/2005 | EP0777492B1 Combinatorial libraries of substrate-bound cyclic organic compounds |
| 01/19/2005 | CN1568370A Treatment of CNS disorders using D-amino acid oxidase and D-aspartate oxidase antagonists |
| 01/19/2005 | CN1568307A Aminopyridyl-substituted phenyl acetamides as protease inhibitors |
| 01/19/2005 | CN1568303A Oligofluorenylene compounds |
| 01/19/2005 | CN1568207A 2-amino-6-(2, 4, 5-substituted-phenyl)-pyridines |
| 01/19/2005 | CN1568185A Compounds effecting glucokinase |
| 01/19/2005 | CN1566097A Purification process for 5-[pair-(2-pyridine sulfamic) benzene] azo salicylic acid |
| 01/19/2005 | CN1566096A Prostaglandin agonists and their use to treat bonedisorders |
| 01/19/2005 | CN1566095A Novel bactericide of 4-[3-(pyridine-4-group)-3-substituted phenyl acryloyl] morpholine |
| 01/19/2005 | CN1566094A Antiviral activity possessed compound |
| 01/19/2005 | CN1566093A Preparation method of pyridine and 3-picoline |
| 01/19/2005 | CN1565736A Catalyzer for synthesizing pyridine base |
| 01/19/2005 | CN1185223C Novel Compounds and methods for synthesis and therapy |
| 01/19/2005 | CN1185220C Para-amino substituted phenylamide glucokinase activators |
| 01/19/2005 | CN1185219C Trans olefinic glucokinase activators |
| 01/19/2005 | CN1185217C Propanolamine derivatives, processes for their preparation, pharmaceuticals comprising these compounds, and their use |
| 01/19/2005 | CN1185216C Fungicides |
| 01/19/2005 | CN1185211C Benzamide derivatives for the treatment of diseases resulted from cytokines |
| 01/19/2005 | CN1184964C Use of carbonylamino derivatives against CNS disorders |
| 01/18/2005 | US6844441 Hypoglycemic agents; dietetics; gastrointestinal disorders; antidepressants; gastrointestinal disorders; antiinflammatory agents |
| 01/18/2005 | US6844367 Benzamides and related inhibitors of factor Xa |
| 01/18/2005 | US6844364 Stabilization of retinoid compounds |
| 01/18/2005 | US6844032 Liquid crystal compounds having bis(trifluoromethyl) phenyl rings, liquid crystal compositions and liquid crystal display devices |
| 01/13/2005 | WO2005003123A1 Novel pyridine derivatives as jnk specific inhibitors |
| 01/13/2005 | WO2005003103A2 2, 4, 6-tri-substituted 6-membered heterocycles and their use in the treatment of neurodegenerative diseases |
| 01/13/2005 | WO2005003101A2 Pyrazine and pyridine derivatives as rho kinase inhibitors |
| 01/13/2005 | WO2005003094A1 Diarylmethyl derivatives as potassium channel modulators |
| 01/13/2005 | WO2005003093A1 Novel compounds and electrophotographic photoreceptors and electrophotographic apparatus made by using the same |
| 01/13/2005 | WO2005002577A1 Dual nk1/nk3 antagonists for treating schizophrenia |
| 01/13/2005 | WO2005002519A2 Amphiphilic pyridinium compounds, method of making and use thereof |
| 01/13/2005 | WO2004092130A3 N-containing heteroaromatic compounds as modulators of ppars and methods of treating metabolic disorders |
| 01/13/2005 | US20050010052 P2X7 receptor (a ligand-gated ion channel) antagonists for use in the treatment of inflammatory, immune or cardiovascular diseases; osteoarthritis |
| 01/13/2005 | US20050010038 Chelants and macrocyclic metal complex radiopharmaceuticals thereof |
| 01/13/2005 | US20050009920 Taxol enhancer compounds |
| 01/13/2005 | US20050009900 3-Substituted with a heterocyclic group, e.g., 2-Chloro-5-[1-(2,3-dihydroxy-propyl)-5-methyl-1H-pyrazol-3-yl]-N-(1-hydroxy-cycloheptylmethyl)-benzamide; treatment of IL-1 mediated disorders, including osteo- and rheumatoid arthritis, allergies, asthma, COPD, cancer, and reperfusion or ischemia in stroke |
| 01/13/2005 | US20050009883 Fipronil and chloropyridine or chlorothiazole derivatives as antagonists of nicotinic acetylcholine receptors; protection of industrial materials and plants. |
| 01/13/2005 | US20050009879 N-substituted-2-oxodihydropyridine derivatives |
| 01/13/2005 | US20050009875 Antiinflammatory agents |